ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-020-8279, 6505010208279
Cancelled -> Replaced by 6505010454851

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 010208279
Codification Country
United States
Item Name Code
INC 35474
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-020-8279
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-020-8279


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-020-8279

National Stock Number (NSN) 6505-01-020-8279, or NIIN 010208279, (carbidopa and levodopa tablets) was assigned May 6, 1976 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 2 stock numbers: 6505010454851, 6505010083329.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Aug 04, 2016. There has been one contract issued for this part number, with one award given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DX15D9383. The total value of the awarded contracts has been US$ 9,976.32.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 35474. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505010208279 does not contain precious metals.

This information was last updated on .


Technical Characteristics

UNIT OF ISSUE WEIGHT
(SUWT) 0.16 POUNDS
EXTERIOR CONTAINER WEIGHT
(ECWT) 24.00 POUNDS
UNIT OF ISSUE CUBE
(SUCB) 0.009 CUBIC FEET
EXTERIOR CONTAINER CUBIC MEASURE
(EXME) 1.295 CUBIC FEET
INTERMEDIATE PACKAGE QUANTITY
(PKQT) 12
III PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
EXTERIOR CONTAINER QUANTITY
(EXQT) 144
ACTIVE MEDICAMENT MEDICINAL STRENGTH
(AKJA) 25.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND 250.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
MEDICAL DESIGNATION AND GRADE
(MDES) UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER CONTENT QUANTITY
(CRLK) 100.000 TABLETS
PRIMARY CONTAINER TYPE
(CQCT) BOTTLE
MEDICAL DESIGNATION
(MDES) UNITED STATES PHARMACOPEIA

Manufacturer Part Numbers


Related Inventory



 
Top